A predictive nomogram for short-term outcomes of myasthenia gravis patients treated with low-dose rituximab.
Yufan ZhouRongjing GuoXingyu XiaSisi JingJun LuZhe RuanSu-Shan LuoXiao HuanChong-Bo ZhaoTing ChangJianying XiPublished in: CNS neuroscience & therapeutics (2024)
The nomogram achieved an optimal prediction of short-term outcomes in patients treated with low-dose rituximab.